The International Graduate School in Molecular Medicine Ulm funded by the Excellence Initiative of the German Federal and State Governments kindly invites applications from highly qualified and motivated individuals for

9 PhD studentships
to commence in April 2015.

Depending on the project, the successful candidates will perform their PhD projects partly in Ulm and partly in our partner universities abroad.

The International Graduate School in Molecular Medicine Ulm is a central institution of Ulm University providing high quality training for doctoral students in a structured, three year's programme. The scientific bases for the International Graduate School in Molecular Medicine Ulm are externally funded research networks with proven excellence.

Successful candidates are expected to work in one of the following research projects:

Toxin-mediated drug delivery across BBB
Holger Barth (Ulm) and Caesare Montecucco (Padua)

Cellular mechanism of amyloid fibril formation
Marcus Fändrich (Ulm)

BRCC36 mutations in myelodysplastic syndrome
Jan Krönke (Ulm)

Chemokine receptor signalling in adipocyte differentiation
Barbara Möpps (Ulm) and Thomas Kietzmann (Oulu)

Mesenchymal stem cells in tissue aging
Karin Scharffetter-Kochanek (Ulm)

Analysis of human NK-cell deficiency
Klaus Schwarz (Ulm)

Mechanisms of glucocorticoid receptor in osteoporosis
Jan Tuckermann (Ulm)

Synthesis of antiviral inhibitors
Tanja Weil

FOXO transcription factors in B lymphoma
Thomas Wirth (Ulm)

PhD students will receive a PhD position (TVL E13 65%) or a tax-free fellowship of 1400 EUR per month for initially 2,5 years.

Further details:
http://www.nature.com